Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.5.0.1
Consolidated Statements of Operations - USD ($)
11 Months Ended 12 Months Ended
Mar. 31, 2015
Mar. 31, 2016
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development $ 244,635 $ 1,222,194
General and administrative expenses 339,214 2,647,800
Total operating expenses 583,849 3,869,994
Loss from operations (583,849) (3,869,994)
Other income (expense)    
Grant income $ 137,500 264,333
Other income 500
Interest income 1,328
Change in fair value of derivative liabilities (106,994)
Total other income $ 137,500 159,167
Net loss $ (446,349) $ (3,710,827)
Net loss per common share - basic and diluted (in dollars per share) $ (0.08) $ (0.32)
Weighted average common shares outstanding - basic and diluted (in shares) 5,493,200 11,702,313